Effect of adding oxaliplatin to adjuvant 5-fluorouracil/leucovorin (5FU/LV) in patients with defective mismatch repair (dMMR) colon cancer stage II and III included in the MOSIAC study.

Authors: Flejou, J.-F., Hickish, T. et al.

Journal: JOURNAL OF CLINICAL ONCOLOGY

Volume: 31

Issue: 15

eISSN: 1527-7755

ISSN: 0732-183X

Source: Web of Science (Lite)

Preferred by: Tamas Hickish